NYSE - Delayed Quote • USD
Baxter International Inc. (BAX)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:41 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
14,892,000.00
14,813,000.00
14,506,000.00
12,146,000.00
11,673,000.00
Cost of Revenue
9,805,000.00
9,838,000.00
9,440,000.00
7,426,000.00
7,086,000.00
Gross Profit
5,087,000.00
4,975,000.00
5,066,000.00
4,720,000.00
4,587,000.00
Operating Expense
4,666,000.00
4,563,000.00
4,435,000.00
3,384,000.00
3,036,000.00
Operating Income
421,000.00
412,000.00
631,000.00
1,336,000.00
1,551,000.00
Net Non Operating Interest Income Expense
-403,000.00
-442,000.00
-395,000.00
-193,000.00
-134,000.00
Other Income Expense
-20,000.00
-74,000.00
-2,886,000.00
-27,000.00
-125,000.00
Pretax Income
-1,000.00
-103,000.00
-2,650,000.00
1,116,000.00
1,292,000.00
Tax Provision
29,000.00
-34,000.00
4,000.00
83,000.00
182,000.00
Net Income Common Stockholders
2,649,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Diluted NI Available to Com Stockholders
2,649,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Basic EPS
5.23
5.25
-4.83
2.56
2.17
Diluted EPS
5.23
5.25
-4.83
2.53
2.13
Basic Average Shares
506,750.00
506,000.00
504,000.00
502,000.00
509,000.00
Diluted Average Shares
507,250.00
506,000.00
504,000.00
508,000.00
517,000.00
Total Operating Income as Reported
448,000.00
390,000.00
-2,243,000.00
1,350,000.00
1,616,000.00
Total Expenses
14,471,000.00
14,401,000.00
13,875,000.00
10,810,000.00
10,122,000.00
Net Income from Continuing & Discontinued Operation
2,649,000.00
2,656,000.00
-2,433,000.00
1,284,000.00
1,102,000.00
Normalized Income
-20,600.00
-23,070.00
-379,740.00
1,045,150.00
1,208,532.51
Interest Income
85,000.00
70,000.00
20,000.00
14,000.00
19,000.00
Interest Expense
488,000.00
512,000.00
415,000.00
207,000.00
153,000.00
Net Interest Income
-403,000.00
-442,000.00
-395,000.00
-193,000.00
-134,000.00
EBIT
487,000.00
409,000.00
-2,235,000.00
1,323,000.00
1,445,000.00
EBITDA
1,772,000.00
1,672,000.00
-855,000.00
2,190,000.00
2,268,000.00
Reconciled Cost of Revenue
9,805,000.00
9,838,000.00
9,440,000.00
7,426,000.00
7,086,000.00
Reconciled Depreciation
1,285,000.00
1,263,000.00
1,380,000.00
867,000.00
823,000.00
Net Income from Continuing Operation Net Minority Interest
-38,000.00
-76,000.00
-2,666,000.00
1,022,000.00
1,102,000.00
Total Unusual Items Excluding Goodwill
-29,000.00
-79,000.00
-2,894,000.00
-25,000.00
-124,000.00
Total Unusual Items
-29,000.00
-79,000.00
-2,894,000.00
-25,000.00
-124,000.00
Normalized EBITDA
1,801,000.00
1,751,000.00
2,039,000.00
2,215,000.00
2,392,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-11,600.00
-26,070.00
-607,740.00
-1,850.00
-17,467.49
12/31/2020 - 10/27/1981
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDX Becton, Dickinson and Company
236.30
-0.14%
RMD ResMed Inc.
218.57
-0.64%
XRAY DENTSPLY SIRONA Inc.
28.28
-0.35%
EMBC Embecta Corp.
14.45
+1.76%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
HOLX Hologic, Inc.
75.02
+0.09%
TFX Teleflex Incorporated
217.64
-0.43%
ALC Alcon Inc.
88.83
-0.26%
COO The Cooper Companies, Inc.
97.31
-0.60%
MMSI Merit Medical Systems, Inc.
81.89
-0.45%